Theravance Biopharma - VIBATIV - Ownership and Business Overview

Life ScienceCompany

Theravance Biopharma - VIBATIV Ownership

Who owns Theravance Biopharma - VIBATIV?

Theravance Biopharma - VIBATIV is owned by Cumberland Pharmaceuticals. It was acquired on November 6, 2018.

Theravance Biopharma - VIBATIV Business Overview

Where is Theravance Biopharma - VIBATIV headquartered?

Theravance Biopharma - VIBATIV is headquartered in South San Francisco, California.

What sector is Theravance Biopharma - VIBATIV in?

Theravance Biopharma - VIBATIV is a life science company.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 247 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 203 by strategics.

Theravance Biopharma, Inc. - VIBATIV

901 Gateway Blvd.,
South San Francisco, California 94080
United States,
(855) 633-8479
www.vibativ.com

Theravance Biopharma, Inc. - VIBATIV is patented, FDA approved anti-infective for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia and complicated skin & skin structure infections. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.